123 related articles for article (PubMed ID: 8178310)
1. Release of von Willebrand factor by cardiopulmonary bypass, but not by cardioplegia in open heart surgery.
Valen G; Blombäck M; Sellei P; Lindblom D; Vaage J
Thromb Res; 1994 Jan; 73(1):21-9. PubMed ID: 8178310
[TBL] [Abstract][Full Text] [Related]
2. The effects of cardiopulmonary bypass on systemic and coronary levels of von Willebrand factor.
Holdright DR; Hunt BJ; Parratt R; Segal H; Clarke D; Taggart D; Bennett G; Collins P
Eur J Cardiothorac Surg; 1995; 9(1):18-21. PubMed ID: 7727141
[TBL] [Abstract][Full Text] [Related]
3. Open heart surgery increases the levels of histamine in arterial and coronary sinus blood.
Valen G; Kaszaki J; Nagy S; Vaage J
Agents Actions; 1994 Mar; 41(1-2):11-6. PubMed ID: 8079813
[TBL] [Abstract][Full Text] [Related]
4. Systemic release of thrombomodulin, but not from the cardioplegic, reperfused heart during open heart surgery.
Valen G; Sigurdardottir O; Vaage J
Thromb Res; 1996 Aug; 83(4):321-8. PubMed ID: 8870176
[TBL] [Abstract][Full Text] [Related]
5. Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery.
Solomon C; Budde U; Schneppenheim S; Czaja E; Hagl C; Schoechl H; von Depka M; Rahe-Meyer N
Br J Anaesth; 2011 Apr; 106(4):494-500. PubMed ID: 21278152
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood.
Valen G; Eriksson E; Risberg B; Vaage J
Eur J Cardiothorac Surg; 1994; 8(6):324-30. PubMed ID: 8086178
[TBL] [Abstract][Full Text] [Related]
7. Is hypothermia a benefit? Von Willebrand factor in pediatric cardiopulmonary bypass.
Bec L; Karolczak MA; Motylewicz B; Rogala E
J Cardiovasc Surg (Torino); 2006 Apr; 47(2):211-5. PubMed ID: 16572096
[TBL] [Abstract][Full Text] [Related]
8. CD11b may be a less satisfactory indicator for cardiac ischemia-reperfusion injury in coronary artery bypass graft surgery with cardiopulmonary bypass than cardiac troponin I.
Li C; Zhao W; Wu K; Zhang J; Jia N
J Clin Anesth; 2005 May; 17(3):158-62. PubMed ID: 15896579
[TBL] [Abstract][Full Text] [Related]
9. von Willebrand factor and urinary albumin excretion are possible indicators of endothelial dysfunction in cardiopulmonary bypass.
Tsang GM; Allen S; Pagano D; Wong C; Graham TR; Bonser RS
Eur J Cardiothorac Surg; 1998 Apr; 13(4):385-91. PubMed ID: 9641336
[TBL] [Abstract][Full Text] [Related]
10. Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery.
Hernández-Romero D; Lahoz Á; Roldan V; Jover E; Romero-Aniorte AI; Martinez CM; Jara-Rubio R; Arribas JM; Garcia-Alberola A; Cánovas S; Valdés M; Marín F
Europace; 2016 Sep; 18(9):1328-34. PubMed ID: 26566941
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline preloading reduces endothelial injury and permeability in cardiopulmonary bypass.
Tsang GM; Allen S; Pagano D; Wong C; Graham TR; Bonser RS
ASAIO J; 1996; 42(5):M429-34. PubMed ID: 9063959
[TBL] [Abstract][Full Text] [Related]
12. The heparin-von Willebrand factor interaction and conventional tests of haemostasis - the challenges in predicting bleeding in cardiopulmonary bypass.
Ranger A; Gaspar M; Elkhatteb A; Jackson T; Fox S; Aw TC; Vipond L; Cotterill J; Ghori A; Laffan M; Arachchillage DRJ
Br J Haematol; 2021 Mar; 192(6):1073-1081. PubMed ID: 33278841
[TBL] [Abstract][Full Text] [Related]
13. Relatively increased von Willebrand factor activity after off-pump coronary artery bypass graft surgery.
Lo B; Nierich AP; Kalkman CJ; Fijnheer R
Thromb Haemost; 2007 Jan; 97(1):21-6. PubMed ID: 17200766
[TBL] [Abstract][Full Text] [Related]
14. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
Gersak B; Sutlic Z
Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
[TBL] [Abstract][Full Text] [Related]
15. Effect of cold blood cardioplegia enriched with potassium-magnesium aspartate during coronary artery bypass grafting.
Ji B; Liu J; Liu M; Feng Z; Wang G; Lu F; Long C
J Cardiovasc Surg (Torino); 2006 Dec; 47(6):671-5. PubMed ID: 17043614
[TBL] [Abstract][Full Text] [Related]
16. Release of creatine kinase, troponin-T, and tissue plasminogen activator in arterial and coronary venous blood during coronary artery bypass surgery.
Valen G; Owall A; Eriksson E; Kallner A; Risberg B; Vaage J
Scand J Clin Lab Invest; 1997 Feb; 57(1):85-93. PubMed ID: 9127461
[TBL] [Abstract][Full Text] [Related]
17. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
[TBL] [Abstract][Full Text] [Related]
18. Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery.
Feldmann C; Zayat R; Goetzenich A; Aljalloud A; Woelke E; Maas J; Tewarie L; Schmitz-Rode T; Autschbach R; Steinseifer U; Moza A
PLoS One; 2017; 12(2):e0171029. PubMed ID: 28234916
[TBL] [Abstract][Full Text] [Related]
19. Changes in factor VIII proteins after cardiopulmonary bypass in man suggest endothelial damage.
Jones DK; Luddington R; Higenbottam TW; Scott J; Cavarocchi N; Reardon D; Calvin J; Wallwork J
Thromb Haemost; 1988 Oct; 60(2):199-204. PubMed ID: 2975406
[TBL] [Abstract][Full Text] [Related]
20. Beta-blockade versus Buckberg blood-cardioplegia in coronary bypass operation.
Kuhn-Régnier F; Natour E; Dhein S; Dapunt O; Geissler HJ; LaRosé K; Görg C; Mehlhorn U
Eur J Cardiothorac Surg; 1999 Jan; 15(1):67-74. PubMed ID: 10077376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
